CFA
ACER

CWS Financial Advisors’s Acer Therapeutics Inc ACER Stock Holding History

CWS Financial Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,000
Closed -$40K – 137
2020
Q1 		$40K Hold
10,000
– – 0.03% 124
2019
Q4 		$40K Buy
+10,000
New +$34K 0.03% 124

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CWS Financial Advisors's ACER Position: Q2 2020 in Review

CWS Financial Advisors sold out of Acer Therapeutics Inc (ACER) in Q2 2020, closing a stake of 10,000 shares — an estimated $40K sold.

CWS Financial Advisors first reported a position in ACER in Q4 2019 and held it in 2 quarters. The position peaked at $40K in Q1 2020. 34 funds tracked by Wall St. Rank hold ACER as of Q2 2020.

  • CWS Financial Advisors reported no remaining Acer Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • CWS Financial Advisors sold 10,000 Acer Therapeutics Inc shares in Q2 2020, an estimated $40K.
  • CWS Financial Advisors first reported a position in Acer Therapeutics Inc in Q4 2019 and held it in 2 quarters.
  • CWS Financial Advisors's Acer Therapeutics Inc position peaked at $40K in Q1 2020.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2020.

Based on CWS Financial Advisors's 13F filing for Q2 2020, filed 11 Aug 2020.